New York, NY -- (ReleaseWire) -- 04/01/2013 --D.E. MASTER BLENDERS (Pink:DEMBF) traded at $ 15.31 in the last session, which is +3.10 (25.39%). The stock has a Range of 15.30 - 15.58. The stock has a 52 week low and high of 10.30 - 15.58 respectively. The stock has a Market Cap of 7.26B. The stock traded a volume of 964,662.00. The stock has a 30 day average volume of 214,366.00.
D.E MASTER BLENDERS 1753 N.V. produces and sells coffee and tea products for retail and out of home markets. The company’s principal products include roast and ground multi-serve coffee, roast and ground single-serve coffee pads and capsules, instant coffee, and tea under the Douwe Egberts, L’OR, Maison du Café, Marcilla, Merrild, Kanis & Gunnink, Jacqmotte, Senseo, L’OR EspressO, L’aRôme EspressO, Pickwick, Pilão, Caboclo, Damasco and Moka, Harris, and Moccona brands.
Find out where DEMBF could be headed in the upcoming trading sessions here: http://stockreportdaily.com/market-scan/?symbol=DEMBF
Roche Holding AG (OTC:RHHBY) announced that the subcutaneous injectable version of its rheumatoid arthritis (:RA) drug Actemra (tocilizumab) has been approved by the Japanese health authorities. The subcutaneous version of the drug has been approved for treating RA patients who have not responded adequately to one or more existing medications for the disease.
RHHBY noted that a phase III study, conducted in Japan, demonstrated that the subcutaneous version of Actemra was as effective as its intravenous formulation. Moreover, the safety profiles of both versions were comparable. The subcutaneous version of the RA drug is currently under review in the US and the EU.
Get the latest trend analysis reports on RHHBY here:
Stockreportdaily.com issues momentum alerts on stocks that can provide gains to day traders. Stockreportdaily.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. Stockreportdaily.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Stockreportdaily.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Stockreportdaily.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Stockreportdaily.com
Stockreportdaily.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Stockreportdaily.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit; http://www.Stockreportdaily.com/disclaimer/
Stock Report Daily